Related references
Note: Only part of the references are listed.Predictability of Neutrophil to Lymphocyte Ratio in preoperative elderly hip fracture patients for post-operative short-term complications: a retrospective study
Mohammad Golsorkhtabaramiri et al.
BMC MUSCULOSKELETAL DISORDERS (2023)
Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
Jie Tao et al.
CARDIOVASCULAR DIABETOLOGY (2023)
Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening
Shohei Burns et al.
DIGESTIVE DISEASES AND SCIENCES (2023)
A low BUN/creatinine ratio predicts histologically confirmed acute interstitial nephritis
Lopez Giacoman Salvador et al.
BMC NEPHROLOGY (2023)
D-dimer to lymphocyte ratio can serve as a potential predictive and prognostic value in colorectal cancer patients with liver metastases
Shaolong Lu et al.
BMC SURGERY (2023)
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
Hikari Chidimatsu et al.
ANTICANCER RESEARCH (2023)
Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer
Gowhar Rashid et al.
FRONTIERS IN MEDICINE (2023)
Trends of colorectal cancer screening methods: an analysis of Behavioral Risk Factor Surveillance System data from 2018-2020
Gregory Balcerak et al.
JOURNAL OF OSTEOPATHIC MEDICINE (2023)
What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Monika Gudowska-Sawczuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
Monika Zajkowska et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis
Zhengyuan Huang et al.
BIOMED RESEARCH INTERNATIONAL (2022)
Chemokine Homeostasis in Healthy Volunteers and during Pancreatic and Colorectal Tumor Growth in Murine Models
Elena Svirshchevskaya et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)
Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer
Xi Yang et al.
Aging-US (2021)
Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
Monika Zajkowska et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Leilani Lakemeyer et al.
DISEASES (2021)
Eotaxins and Their Receptor in Colorectal Cancer-A Literature Review
Monika Zajkowska et al.
CANCERS (2020)
Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
Monika Gudowska-Sawczuk et al.
BRAIN SCIENCES (2020)
Biomarkers in Colorectal Cancer: Current Research and Future Prospects
Olorunseun O. Ogunwobi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma
Monika Gudowska-Sawczuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer
Stephanie A. Bien et al.
HUMAN GENETICS (2019)
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome
Manar AbdelMageed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CCL26 Participates in the PRL-3-Induced Promotion of Colorectal Cancer Invasion by Stimulating Tumor-Associated Macrophage Infiltration
Qiusheng Lan et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer
Malgorzata Krzystek-Korpacka et al.
CYTOKINE (2018)
Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives
Gianluca Pellino et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)
Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis
Susumu Inamoto et al.
CLINICAL CANCER RESEARCH (2016)
Expression and effect of CXCL14 in colorectal carcinoma
Kezhi Lin et al.
MOLECULAR MEDICINE REPORTS (2014)
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
Mikio Kawamura et al.
EUROPEAN JOURNAL OF CANCER (2012)
Eotaxin-2 and colorectal cancer: A potential target for immune therapy
Eleanor J. Cheadle et al.
CLINICAL CANCER RESEARCH (2007)